Clinical Lymphoma, Myeloma & Leukemia
Publisher: Elsevier · ISSN 2152-2650 · 71 articles
- Right ventricular global longitudinal strain derived by cardiac magnetic resonance in cardiac light-chain amyloidosis: improved prognostic model fit beyond staging and greater discrimination than echocardiography — a retrospective cohort study
- Revumenib in Pediatric Acute Leukemia: Clinical Activity and Differentiation Syndrome from the AUGMENT-101 Study
- “Whole-Blood Epstein–Barr Virus DNA in Immunocompetent Primary CNS Lymphoma patients: A Prospective Exploratory Case–Control Study”
- Ataxia and Balance Disorders Associated with GPRC5D-Directed Therapies in Relapsed/Refractory Multiple Myeloma: A Case Series with Practical Recommendations for Management
- Bone Marrow Fibrosis Is Associated with Inferior Survival in Lower-Risk Myelodysplastic Syndromes and Adds Prognostic Information to IPSS-R and IPSS-M
- Radiation Therapy as Salvage or Bridging Before CAR T-Cell Therapy Improves Outcomes in Aggressive B-Cell Lymphomas with Higher-Risk Features
- Use and safety of peripherally inserted venous catheters vs central venous catheters for patients with lymphoma receiving frontline anthracycline-based chemotherapy
- BCMA-directed antibodies in multiple myeloma: new agents and treatment strategies from IMS 2026
- First-line tislelizumab, pegaspargase, and gemcitabine with consolidative radiotherapy for early-stage extranodal NK/T-cell lymphoma: a single-arm, phase II trial
- Editorial Board
- Table of Contents
- SOHO State of the Art Updates and Next Questions | The Role of Maintenance Therapy Following Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma
- SOHO State of the Art Updates and Next Questions | Chronic Myeloid Leukemia in Low- and Middle-Income Countries: Increasing Access to Tyrosine Kinase Inhibitors and Supporting Treatment Free Remission
- Infection Prevention and Management in Patients With Multiple Myeloma Treated With Bispecific Antibodies: A Case-Based Approach for Routine Clinical Practice
- Gut Microbiome Composition Is Associated With Response to CD38 Antibody (Daratumumab) Treatment Among Relapsed Multiple Myeloma Patients
- Identification of the Characteristics and Prognostic Impact of t(3;5)(q25;q35)/NPM1::MLF1 Fusion Genes and NPM1 Mutations in Acute Myeloid Leukemia Patients
- A Single-center Retrospective Study of MIAD ± R Chemotherapy in Newly Diagnosed Primary Central Nervous System Lymphoma: Safety Profiles and Clinical Outcomes
- Patient-reported Outcomes and Healthcare Provider Perspectives on Subcutaneous Isatuximab Delivery via On-body Injector Versus Manual Injection: Results From the Phase 2 IZALCO Study in Relapsed/Refractory Multiple Myeloma
- Rituximab Versus Watchful Waiting for Asymptomatic Advanced-Stage Low-Tumor-Burden Follicular Lymphoma: A Systematic Review and Meta-Analysis
- Clinical Characteristics and Prognostic Analysis of Pediatric Acute Myeloid Leukemia With CBFB::MYH11: A 10-Year Single-Center Cohort Study
- Outcomes of Patients With Acute Promyelocytic Leukemia in Jordan: Real-World Data from a Tertiary Referral Center
- Long-Term Progression-Free Survival in Patients Treated With RVD Induction and Risk-Adapted Maintenance
- Real-World Experience With Mogamulizumab for Mycosis Fungoides and Sézary Syndrome
- Progression of Disease Within 24 Months (POD24) is an Independent Prognostic Factor for Survival in Waldenström Macroglobulinemia
- Acute Leukemia During the First Six Months of Life: A Population-Based Analysis of Survival by Leukemia Type
- Comment On: ``2026 Myeloma Treatment Guidelines of the Turkish Myeloma Study Group''
- Testicular Plasmacytoma: A 25-Year Experience From a High-Volume Tertiary Center and Comparative Review of the Literature
- Cutaneous Toxicities of T-Cell–Redirecting Therapies in Multiple Myeloma: An EADV Task Force Position Paper and Practical Recommendations
- Noninterchangeability of Serum-Free Light Chain Assays at IMWG Thresholds: Analysis of 2117 Paired Samples
- Changing Patterns of Causes of Death in Patients With Multiple Myeloma During the Modern Therapeutic Era